Inquiry at Harvard prompts research paper corrections

Article Abstract:

Three physicians from Harvard Medical School have made extensive corrections in the results of research conducted on the treatment of hemangiomas, rare but sometimes fatal birthmarks found in newborns. An investigation of the research found several serious errors which needed to be corrected, although no evidence of misconduct was cited. This research was conducted by R. Alan B. Ezekowitz, John B. Mulliken and Judah Folkman. Researchers found the interferon alfa-2a to be the best treatment for the birthmarks.

Reports, Medical research, Harvard University. School of Medicine, Medical errors

---

US jury split over hormone patent case...

Article Abstract:

The jury in the eight-week Genentech trial has failed to reach a unanimous agreement on whether Genentech Inc infringed the University of California's patent for DNA for human growth hormone. A further hearing is to be held, when university attorneys will seek a new patent infringement trial. Genentech attorneys plan to allege that the university's patent was obtained fraudulently.

Investigations, Intellectual property, Genentech Inc., Biotechnology, GNE

---

DIY microarrayers promise DNA chips with everything

Article Abstract:

Californian scientists have developed a website with instructions on how to build a microarray system for making custom chips. A researcher could build a microarrayer for around $30,000 using the website, half the cost of a commercial machine. The scientists also offer a 'freeware' database designed for microarray data.

Research, Semiconductor chips, Integrated circuits

Similar abstracts:

• Abstracts: House backs curb on genetic information. Ethical terms set for breast cancer test. Panel softens cancer gene test warning
• Abstracts: Energy implications of future stabilization of atmospheric CO2 content. Deriving global climate sensitivity from palaeoclimate reconstructions
• Abstracts: Requiem for the Chesapeake. Tigers get a business plan. The oyster bar: can Chesapeake Bay's main mollusc survive?
• Abstracts: A telomerase component is defective in the human disease dyskeratosis congenita. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
• Abstracts: A century of cognitive decline: If we live long enough, will we all become demented?

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.